Jones Financial Companies’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187M Buy
1,791,866
+383,604
+27% +$34.2M 0.07% 134
2026
Q1
$98.7M Buy
1,408,262
+1,067,420
+313% +$82.2M 0.05% 202
2025
Q4
$27M Buy
340,842
+3,884
+1% +$306K 0.02% 276
2025
Q3
$25.5M Buy
336,958
+43,621
+15% +$2.99M 0.02% 252
2025
Q2
$20.1M Buy
293,337
+81,436
+38% +$5.34M 0.02% 255
2025
Q1
$14.2M Buy
211,901
+66,890
+46% +$4M 0.01% 260
2024
Q4
$6.51M Buy
145,011
+22,994
+19% +$1.29M 0.01% 317
2024
Q3
$7.5M Buy
122,017
+51,531
+73% +$3.01M 0.01% 240
2024
Q2
$4.16M Buy
70,486
+50,409
+251% +$3.15M ﹤0.01% 226
2024
Q1
$1.6M Buy
20,077
+9,882
+97% +$755K ﹤0.01% 215
2023
Q4
$805K Sell
10,195
-4,740
-32% -$337K ﹤0.01% 216
2023
Q3
$1.04M Buy
14,935
+5,232
+54% +$371K ﹤0.01% 183
2023
Q2
$671K Sell
9,703
-958
-9% -$68.2K ﹤0.01% 199
2023
Q1
$792K Sell
10,661
-530
-5% -$44.4K ﹤0.01% 192
2022
Q4
$1.04M Sell
11,191
-868
-7% -$83.8K ﹤0.01% 180
2022
Q3
$1.15M Sell
12,059
-295
-2% -$29.2K ﹤0.01% 159
2022
Q2
$1.15M Buy
12,354
+122
+1% +$11.9K ﹤0.01% 156
2022
Q1
$1.24M Buy
12,232
+867
+8% +$91.1K ﹤0.01% 156
2021
Q4
$1.17M Sell
11,365
-673
-6% -$62.2K ﹤0.01% 149
2021
Q3
$1.02M Buy
12,038
+314
+3% +$26.3K ﹤0.01% 149
2021
Q2
$978K Sell
11,724
-1,079
-8% -$88.4K ﹤0.01% 150
2021
Q1
$963K Buy
12,803
+4,690
+58% +$342K ﹤0.01% 152
2020
Q4
$554K Sell
8,113
-62
-0.8% -$4.03K ﹤0.01% 163
2020
Q3
$477K Buy
8,175
+499
+7% +$31K ﹤0.01% 163
2020
Q2
$499K Sell
7,676
-495
-6% -$31.2K ﹤0.01% 159
2020
Q1
$485K Sell
8,171
-1,556
-16% -$104K ﹤0.01% 160
2019
Q4
$723K Sell
9,727
-837
-8% -$58.8K ﹤0.01% 156
2019
Q3
$667K Buy
10,564
+1,729
+20% +$102K ﹤0.01% 155
2019
Q2
$481K Sell
8,835
-4,598
-34% -$248K ﹤0.01% 164
2019
Q1
$725K Sell
13,433
-2,343
-15% -$145K ﹤0.01% 154
2018
Q4
$1.03M Sell
15,776
-3,052
-16% -$228K ﹤0.01% 143
2018
Q3
$1.48M Sell
18,828
-285
-1% -$20.4K ﹤0.01% 132
2018
Q2
$1.23M Sell
19,113
-6,596
-26% -$435K ﹤0.01% 137
2018
Q1
$1.6M Sell
25,709
-3,582
-12% -$257K ﹤0.01% 134
2017
Q4
$2.12M Sell
29,291
-2,903
-9% -$211K 0.01% 129
2017
Q3
$2.62M Sell
32,194
-5,946
-16% -$470K 0.01% 122
2017
Q2
$3.07M Sell
38,140
-3,974
-9% -$314K 0.01% 116
2017
Q1
$3.31M Sell
42,114
-5,965
-12% -$476K 0.01% 112
2016
Q4
$3.79M Sell
48,079
-11,309
-19% -$915K 0.01% 109
2016
Q3
$5.29M Sell
59,388
-13,407
-18% -$1.27M 0.02% 85
2016
Q2
$6.97M Sell
72,795
-18,724
-20% -$1.87M 0.03% 70
2016
Q1
$9.49M Buy
91,519
+874
+1% +$85K 0.06% 49
2015
Q4
$8.86M Buy
90,645
+192
+0.2% +$18.8K 0.06% 52
2015
Q3
$8.73M Buy
90,453
+7,756
+9% +$815K 0.06% 50
2015
Q2
$8.67M Sell
82,697
-72
-0.1% -$7.36K 0.06% 52
2015
Q1
$8.54M Sell
82,769
-9,212
-10% -$932K 0.06% 52
2014
Q4
$8.86M Sell
91,981
-41
-0% -$3.61K 0.06% 50
2014
Q3
$7.32M Buy
92,022
+6,717
+8% +$530K 0.05% 54
2014
Q2
$6.43M Sell
85,305
-184
-0.2% -$13.9K 0.05% 59
2014
Q1
$6.4M Buy
85,489
+6,952
+9% +$491K 0.05% 57
2013
Q4
$5.62M Buy
78,537
+4,574
+6% +$294K 0.05% 65
2013
Q3
$4.2M Buy
73,963
+7,993
+12% +$476K 0.04% 71
2013
Q2
$3.77M Buy
+65,970
New +$3.82M 0.04% 71

Other funds holding CVS

Jones Financial Companies's CVS Position: Q2 2026 in Review

Jones Financial Companies increased its CVS Health (CVS) stake by 27% in Q2 2026, buying an estimated $34.2M and bringing the position to 1,791,866 shares worth $187M. The position accounts for 0.07% of the portfolio, ranked #134.

Jones Financial Companies first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Jones Financial Companies held 1,791,866 shares of CVS Health worth $187M as of Q2 2026.
  • Jones Financial Companies bought 383,604 CVS Health shares in Q2 2026, an estimated $34.2M.
  • CVS Health made up 0.07% of Jones Financial Companies's portfolio in Q2 2026, its #134 holding.
  • Jones Financial Companies first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.